Virinchi Limited , a diversified technology and healthcare company, has announced its board's approval of audited standalone and consolidated financial results for the quarter ended June 30, 2025, along with strategic considerations for its Fin-Tech SaaS vertical, 'QFund'.

Board Approves Q1 FY26 Results

The Board of Directors of Virinchi Limited convened on August 14, 2025, and approved the audited standalone and consolidated financial results for the first quarter of the fiscal year 2026, ending June 30, 2025. The meeting, which commenced at 19:45 and concluded at 20:20, also involved discussions on strategic initiatives for the company's future growth.

Strategic Evaluation of 'QFund'

A significant focus of the board meeting was the strategic evaluation of Virinchi's high-EBITDA Fin-Tech SaaS vertical, 'QFund'. This vertical, which caters to US-based alternative lenders, is being considered for potential restructuring or divestment to enhance shareholder value and support the company's growth initiatives.

The board is exploring two primary options:

1. Restructuring into a Subsidiary: The company is considering restructuring the SaaS business into a 100% subsidiary through a slump sale. This move aims to create a focused SaaS entity, potentially unlocking long-term shareholder value.

2. Partial Divestment: Alternatively, Virinchi is exploring the possibility of divesting a portion of the SaaS business. This could be achieved through private investment, strategic partnerships, or an Initial Public Offering (IPO).

Potential Use of Proceeds

If the company proceeds with a divestment strategy, the board has outlined two primary uses for the potential proceeds:

1. Debt Reduction: A portion of the funds would be allocated to reduce the consolidated debt of the company, potentially improving its financial position.

2. Healthcare Expansion: The company plans to invest in its oncology healthcare vertical, specifically to expand the Virinchi hospital chain. This move aligns with the company's diversified business model, balancing its technology and healthcare operations.

Next Steps

The board has requested further details on these strategic options and has scheduled a follow-up meeting for August 22, 2025, to deliberate further on these matters. This upcoming meeting is expected to provide more clarity on the direction Virinchi Limited will take regarding its 'QFund' vertical and overall business strategy.

Recent Share Pledge Release

In a separate development, the company reported a partial release of pledged shares by promoter Viswanath Kompella. On August 13, 2025, 25,00,000 equity shares were released from pledge by M/s. Badjate Stock Broking Pvt Ltd. Following this transaction, Kompella's total shareholding remains at 1,63,50,888 shares (15.93% of total share capital), with 79,72,679 shares still encumbered.

Investors and stakeholders will be keenly watching for the outcomes of the August 22 board meeting, which could potentially reshape Virinchi Limited's business structure and future growth trajectory.

Virinchi Limited , a company listed on both BSE and NSE, has reported a significant change in its promoter's shareholding structure. According to a disclosure made under SEBI regulations, promoter Viswanath Kompella has seen a partial release of pledged equity shares, impacting the company's ownership distribution.

Key Highlights

• 25,00,000 pledged equity shares were partially released by Badjate Stock Broking Pvt Ltd on August 13, 2025.
• The release was executed off-market through the depository mode.
• Following the transaction, the promoter's shareholding structure has been altered.

Impact on Shareholding

The partial release of pledged shares has resulted in the following changes to Viswanath Kompella's shareholding:

Company Capital Structure

Virinchi Limited's capital structure remains unchanged:

• Equity Share Capital: 10,26,46,896 shares of Rs. 10 each
• Total Voting Capital: Rs. 102,64,68,960
• Diluted Share Capital: 10,86,01,536 shares (including outstanding ESOPs)

The company has 59,54,640 outstanding ESOPs, which are included in the diluted share capital calculation.

Regulatory Compliance

This disclosure was made in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction demonstrates the company's commitment to transparency in reporting changes in promoter shareholding patterns.

The release of pledged shares often indicates a positive development, as it may suggest improved financial flexibility for the promoter. However, investors should consider this information alongside other financial and operational metrics when evaluating the company's overall performance and stability.